136 related articles for article (PubMed ID: 17384678)
1. BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
Yuli C; Shao N; Rao R; Aysola P; Reddy V; Oprea-llies G; Lee L; Okoli J; Partridge E; Reddy ES; Rao VN
Oncogene; 2007 Sep; 26(41):6031-7. PubMed ID: 17384678
[TBL] [Abstract][Full Text] [Related]
2. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
[TBL] [Abstract][Full Text] [Related]
3. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
[TBL] [Abstract][Full Text] [Related]
5. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.
Fan S; Yuan R; Ma YX; Meng Q; Goldberg ID; Rosen EM
Oncogene; 2001 Dec; 20(57):8215-35. PubMed ID: 11781837
[TBL] [Abstract][Full Text] [Related]
6. Growth retardation and tumour inhibition by BRCA1.
Holt JT; Thompson ME; Szabo C; Robinson-Benion C; Arteaga CL; King MC; Jensen RA
Nat Genet; 1996 Mar; 12(3):298-302. PubMed ID: 8589721
[TBL] [Abstract][Full Text] [Related]
7. Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression.
Hu Y; Ghosh S; Amleh A; Yue W; Lu Y; Katz A; Li R
Oncogene; 2005 Dec; 24(56):8343-8. PubMed ID: 16170371
[TBL] [Abstract][Full Text] [Related]
8. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts.
Rao VN; Shao N; Ahmad M; Reddy ES
Oncogene; 1996 Feb; 12(3):523-8. PubMed ID: 8637708
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
Orban TI; Olah E
Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers.
Marot D; Opolon P; Brailly-Tabard S; Elie N; Randrianarison V; Connault E; Foray N; Feunteun J; Perricaudet M
Gene Ther; 2006 Feb; 13(3):235-44. PubMed ID: 16208422
[TBL] [Abstract][Full Text] [Related]
12. BCoR-L1 variation and breast cancer.
Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.
Maniccia AW; Lewis C; Begum N; Xu J; Cui J; Chipitsyna G; Aysola K; Reddy V; Bhat G; Fujimura Y; Henderson B; Reddy ES; Rao VN
J Cell Physiol; 2009 Jun; 219(3):634-41. PubMed ID: 19170108
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by the tumor suppressor protein BRCA1.
Shao N; Chai YL; Shyam E; Reddy P; Rao VN
Oncogene; 1996 Jul; 13(1):1-7. PubMed ID: 8700535
[TBL] [Abstract][Full Text] [Related]
15. Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics.
Kurebayashi J
Breast Cancer; 2009; 16(4):275-80. PubMed ID: 19408071
[TBL] [Abstract][Full Text] [Related]
16. Targeting breast and prostate cancers through their hormone receptors.
Leuschner C; Hansel W
Biol Reprod; 2005 Nov; 73(5):860-5. PubMed ID: 16033998
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
[TBL] [Abstract][Full Text] [Related]
18. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
Lee EY
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
[TBL] [Abstract][Full Text] [Related]
19. Growth suppression and radiosensitivity increase by HMGB1 in breast cancer.
Jiao Y; Wang HC; Fan SJ
Acta Pharmacol Sin; 2007 Dec; 28(12):1957-67. PubMed ID: 18031610
[TBL] [Abstract][Full Text] [Related]
20. Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.
Srinivas G; Annab LA; Gopinath G; Banerji A; Srinivas P
Mol Carcinog; 2004 Jan; 39(1):15-25. PubMed ID: 14694444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
